Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Immunotherapy. University of Alabama School of Medicine, Birmingham, AL, United States

Survival: 9.1 months
Toxicity Grade: 3
Treatments: Immunotherapy
Country: United States
City/State/Province: Birmingham, AL
Hospital: University of Alabama School of Medicine
Journal: Link
Date: 6/2014

This phase 2 study involved 20 recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer patients who had received prior platinum-based chemotherapy. The median patient age was 57 years.

Patients received immunotherapy with EGEN-001, a form of interleukin-12 (IL-12) that stimulates the immune system to attack cancer cells.

The most severe toxicities were of grade 3 and included nausea and vomiting (2 patients), anemia (1 patient), and decreased lymphocyte count (1 patient). Grade 1-2 fever, chills, abdominal pain, and anemia were also reported.

The median overall survival was 9.17 months.

Correspondence: Dr. Ronald D. Alvarez; email:

E-mail to a Friend Email Physician More Information